Strategies for internationalisation in Pharma

J.-L. Cayssials and M. Ranvier

Quarterly selection of articles - Bulletin de la Banque de France, 2016, issue 42, 25-40

Abstract: The French pharmaceutical industry is highly internationalised and its production ranks third in the European Union. The strategies of the top 367 multinational companies fall into three distinct economic models based on the way their trade is oriented. These compagnies contribute significantly to current account surpluses, with a surplus of EUR 6 billion in 2012.

Keywords: globalisation; multinationals; exports; imports; direct investment; Pharma (search for similar items in EconPapers)
JEL-codes: F10 F14 F21 F23 (search for similar items in EconPapers)
Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://publications.banque-france.fr/sites/defaul ... 6-summer.pdf#page=25 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bfr:quarte:2016:42:02

Access Statistics for this article

More articles in Quarterly selection of articles - Bulletin de la Banque de France from Banque de France Banque de France 31 Rue Croix des Petits Champs LABOLOG - 49-1404 75049 PARIS. Contact information at EDIRC.
Bibliographic data for series maintained by Michael brassart ().